Continuous post-market sequential safety surveillance with minimum events to signal.

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorKulldorff, Martin-
Autor(es): dc.creatorSilva, Ivair Ramos-
Data de aceite: dc.date.accessioned2025-08-21T15:32:51Z-
Data de disponibilização: dc.date.available2025-08-21T15:32:51Z-
Data de envio: dc.date.issued2018-02-01-
Data de envio: dc.date.issued2018-02-01-
Data de envio: dc.date.issued2017-
Fonte completa do material: dc.identifierhttp://www.repositorio.ufop.br/handle/123456789/9396-
Fonte completa do material: dc.identifierhttps://www.ine.pt/revstat/pdf/REVSTAT_v15-n3-4.pdf-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/1017983-
Descrição: dc.descriptionContinuous sequential analysis is increasingly used for near real-time post-market drug and vaccine safety surveillance. We explore continuous sequential monitoring when the null cannot be rejected until a minimum number of adverse events have occurred. For fixed alpha, one can simultaneously increase the statistical power and reduce the expected time to signal. We also evaluate continuous sequential analysis with a delayed start until a certain sample size has been attained. This is only useful if the start of the surveillance is delayed for logistical reasons. Tables with exact critical values, statistical power and the average times to signal are provided.-
Formato: dc.formatapplication/pdf-
Idioma: dc.languageen-
Direitos: dc.rightsrestrito-
Palavras-chave: dc.subjectDrug safety-
Palavras-chave: dc.subjectSurveillance-
Palavras-chave: dc.subjectPharmacovigilance-
Palavras-chave: dc.subjectContinuous sequential analysis-
Título: dc.titleContinuous post-market sequential safety surveillance with minimum events to signal.-
Aparece nas coleções:Repositório Institucional - UFOP

Não existem arquivos associados a este item.